Keio University


Established in 1858 by prominent educator and intellectual Yukichi Fukuzawa, Keio University is Japan’s oldest private institution of higher learning. A comprehensive research university, Keio values the pursuit of knowledge through jitsugaku, or empirical science — a concept developed by Fukuzawa that emphasizes applying reason, observation and verification in the search for practical solutions to society’s needs.

Following in his footsteps, Keio University is pioneering the globalization of education in Japan and the establishment of a preeminent center of research and innovation in the world. It has launched a university-wide initiative to spearhead research in the areas of longevity, security and creativity, which will enable people to live better, longer and safer lives.

A global player, Keio University ranked 9th in the Times Higher Education Alma Mater Index: Global Executives 2013 and 36th in the QS Graduate Employability Rankings 2016. It scored among the top 60 universities globally, and the top 10 in Asia, in the 2015 Reuters innovation metric. And Keio University came out on top in a 2015 survey of Japanese university brands by Nikkei BP Consulting.

Every year, Keio University School of Medicine awards the Keio Medical Science Prize, a prestigious award conferred to outstanding researchers in the medical and life sciences. Seven winners of the Keio Medical Science Prize have gone on to become Nobel laureates.

Keio University has more than 33,000 students representing 70 countries and 2,250 full-time faculty. Spread across 6 campuses in the Tokyo region are 10 undergraduate schools and 14 graduate schools.

Keio offers 14 degree programs in English and 26 double-degree programs with international partner institutes. Its wider global network of collaborators includes 300 overseas institutions in 49 countries. Its alumni body is 350,000 strong, connected via 800 domestic and 70 overseas voluntary organizations called Mita-kai. Notable alumni include three prime ministers, two astronauts, and many Olympians and Paralympians.

To find out more about the latest research being conducted at Keio University, visit the Keio Research Highlights page. It describes important scientific findings made by researchers at Keio University.

Visit Keio Research Highlights

Keio University retains sole responsibility for content. © 2017 Keio University.

1 January 2017 - 31 December 2017

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Keio University published between 1 January 2017 - 31 December 2017 which are tracked by the Nature Index.

Hover over the donut graph to view the WFC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

122 59.47 56.47

Outputs by subject (WFC)

Subject AC FC WFC
Physical Sciences 47 26.73 23.73
Life Sciences 51 13.15 13.15
Chemistry 32 21.71 21.71
Earth & Environmental Sciences 1 0.01 0.01

Highlight of the month

Mouth bacteria upsets the bowels

© Burak Karademir/Moment/Getty

© Burak Karademir/Moment/Getty

Bacteria that live in your mouth could end up in the gut and trigger inflammatory bowel disease.

The average person swallows around 1.5 litres of saliva every day, sending a multitude of microbes through the body. Disturbances in gut flora, the gut’s microbial community, are thought to cause conditions such as inflammatory bowel disease (IBD), but tracing the source of inflammation has been difficult.

A team led by researchers from Keio University fed saliva from humans with IBD to healthy mice. After six weeks, they analysed the mice’s faeces and identified the presence of around 20 different human oral bacteria. There was a particular abundance of the Klebsiella — a harmless oral inhabitant when present in healthy humans. The team injected Klebsiella into a new batch of mice and found that it activated immune cells and triggered inflammation in the guts.

Additionally, Klebsiella triggered more inflammation in mice treated with antibiotics, suggesting that medicines that modify gut microbes could make patients more susceptible to bowel disease.

Supported content

  1. Science 358, 359-365 (2017). doi: 10.1126/science.aan4526

View the article on the Nature Index

See more research highlights from Keio University

More research highlights from Keio University

1 January 2017 - 31 December 2017

International vs. domestic collaboration by WFC

  • 64.18% Domestic
  • 35.82% International

Note: Hover over the graph to view the percentage of collaboration.

Note: Collaboration is determined by the weighted fractional count (WFC), which is listed in parentheses.

Affiliated joint institutions and consortia

Return to institution outputs